ELEVANCE HEALTH, INC. Available-for-sale Securities, Gross Realized Gains
ELEVANCE HEALTH, INC. (ELV) reported Available-for-sale Securities, Gross Realized Gains of $51.00 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-28.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2020-10-28
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for the quarter ending 2020-09-30 was $51.00M, a 96.15% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for the quarter ending 2020-06-30 was $37.00M, a 68.18% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for the quarter ending 2020-03-31 was $43.00M, a 138.89% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for the quarter ending 2019-09-30 was $26.00M, a 116.67% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for fiscal 2017 was $277.00M, a 34.45% decline from fiscal 2016.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for fiscal 2016 was $422.60M, a 12.90% increase from fiscal 2015.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for fiscal 2015 was $374.30M, a 22.80% increase from fiscal 2014.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized gains for fiscal 2014 was $304.80M, a 41.69% decline from fiscal 2013.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 3 month as first filed | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 6 month as first filed | Available-for-sale Securities, Gross Realized Gains 9 month | Available-for-sale Securities, Gross Realized Gains 9 month as first filed | Available-for-sale Securities, Gross Realized Gains 12 month | Available-for-sale Securities, Gross Realized Gains 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $51.00M 10-Q · filed 2020-10-28 | $88.00M derived: sum of 2 quarters · filed 2020-10-28 | $131.00M 10-Q · filed 2020-10-28 | |||||
| 2020-06-30 | $37.00M 10-Q · filed 2020-07-29 | $80.00M 10-Q · filed 2020-07-29 | ||||||
| 2020-03-31 | $43.00M 10-Q · filed 2020-04-29 | |||||||
| 2019-09-30 | $26.00M 10-Q · filed 2020-10-28 | $48.00M derived: sum of 2 quarters · filed 2020-10-28 | $66.00M 10-Q · filed 2020-10-28 | |||||
| 2019-06-30 | $22.00M 10-Q · filed 2020-07-29 | $40.00M 10-Q · filed 2020-07-29 | ||||||
| 2019-03-31 | $18.00M 10-Q · filed 2020-04-29 | |||||||
| 2018-09-30 | $12.00M 10-Q · filed 2019-10-23 | $42.90M derived: sum of 2 quarters · filed 2019-10-23 | $73.00M 10-Q · filed 2019-10-23 | $216.90M derived: sum of 4 quarters · filed 2019-10-23 | ||||
| 2018-06-30 | $30.90M 10-Q · filed 2018-07-25 | $61.00M 10-Q · filed 2019-07-24 | $60.60M 10-Q · filed 2018-07-25 | $204.90M derived: sum of 3 quarters · filed 2019-07-24 | $251.90M derived: sum of 4 quarters · filed 2019-07-24 | |||
| 2018-03-31 | $31.00M 10-Q · filed 2019-07-24 | $29.70M 10-Q · filed 2018-04-25 | $174.00M derived: sum of 2 quarters · filed 2019-07-24 | $221.00M derived: sum of 3 quarters · filed 2019-07-24 | $262.20M derived: sum of 4 quarters · filed 2019-07-24 | |||
| 2017-12-31 | $143.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $190.00M derived: sum of 2 quarters · filed 2018-10-31 | $231.20M derived: sum of 3 quarters · filed 2018-10-31 | $277.00M 10-K · filed 2018-02-21 | ||||
| 2017-09-30 | $47.00M 10-Q · filed 2018-10-31 | $144.40M 10-Q · filed 2017-10-25 | $88.20M derived: sum of 2 quarters · filed 2018-10-31 | $134.00M 10-Q · filed 2018-10-31 | $255.10M 10-Q · filed 2017-10-25 | $213.10M derived: sum of 4 quarters · filed 2018-10-31 | ||
| 2017-06-30 | $41.20M 10-Q · filed 2018-07-25 | $50.90M 10-Q · filed 2017-07-26 | $86.70M 10-Q · filed 2018-07-25 | $110.70M 10-Q · filed 2017-07-26 | $166.10M derived: sum of 3 quarters · filed 2018-07-25 | $279.50M derived: sum of 4 quarters · filed 2018-07-25 | ||
| 2017-03-31 | $45.50M 10-Q · filed 2018-04-25 | $59.80M 10-Q · filed 2017-04-26 | $124.90M derived: sum of 2 quarters · filed 2018-04-25 | $238.30M derived: sum of 3 quarters · filed 2018-04-25 | $346.70M derived: sum of 4 quarters · filed 2018-04-25 | |||
| 2016-12-31 | $79.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $192.80M derived: sum of 2 quarters · filed 2018-02-21 | $301.20M derived: sum of 3 quarters · filed 2018-02-21 | $422.60M 10-K · filed 2018-02-21 | ||||
| 2016-09-30 | $113.40M 10-Q · filed 2017-10-25 | $221.80M derived: sum of 2 quarters · filed 2017-10-25 | $343.20M 10-Q · filed 2017-10-25 | $385.90M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $108.40M 10-Q · filed 2017-07-26 | $229.80M 10-Q · filed 2017-07-26 | $272.50M derived: sum of 3 quarters · filed 2018-02-21 | $322.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $121.40M 10-Q · filed 2017-04-26 | $164.10M derived: sum of 2 quarters · filed 2018-02-21 | $213.60M derived: sum of 3 quarters · filed 2018-02-21 | $362.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $42.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $92.20M derived: sum of 2 quarters · filed 2018-02-21 | $240.60M derived: sum of 3 quarters · filed 2018-02-21 | $374.30M 10-K · filed 2018-02-21 | $509.10M 10-K · filed 2016-02-19 | |||
| 2015-09-30 | $49.50M 10-Q · filed 2016-11-02 | $197.90M derived: sum of 2 quarters · filed 2016-11-02 | $331.60M 10-Q · filed 2016-11-02 | $414.90M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $148.40M 10-Q · filed 2016-07-27 | $282.10M 10-Q · filed 2016-07-27 | $365.40M derived: sum of 3 quarters · filed 2017-02-22 | $397.80M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $133.70M 10-Q · filed 2016-04-27 | $217.00M derived: sum of 2 quarters · filed 2017-02-22 | $249.40M derived: sum of 3 quarters · filed 2017-02-22 | $355.60M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $83.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $115.70M derived: sum of 2 quarters · filed 2017-02-22 | $221.90M derived: sum of 3 quarters · filed 2017-02-22 | $304.80M 10-K · filed 2017-02-22 | $317.80M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $32.40M 10-Q · filed 2015-10-28 | $138.60M derived: sum of 2 quarters · filed 2015-10-28 | $221.50M 10-Q · filed 2015-10-28 | $389.30M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $106.20M 10-Q · filed 2015-07-29 | $189.10M 10-Q · filed 2015-07-29 | $356.90M derived: sum of 3 quarters · filed 2016-02-19 | $532.90M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $82.90M 10-Q · filed 2015-04-29 | $250.70M derived: sum of 2 quarters · filed 2016-02-19 | $426.70M derived: sum of 3 quarters · filed 2016-02-19 | $498.60M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $167.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $343.80M derived: sum of 2 quarters · filed 2016-02-19 | $415.70M derived: sum of 3 quarters · filed 2016-02-19 | $522.70M 10-K · filed 2016-02-19 | $498.10M 10-K · filed 2014-02-20 | |||
| 2013-09-30 | $176.00M 10-Q · filed 2014-10-29 | $160.40M 10-Q · filed 2013-10-23 | $247.90M derived: sum of 2 quarters · filed 2014-10-29 | $354.90M 10-Q · filed 2014-10-29 | $339.30M 10-Q · filed 2013-10-23 | $474.30M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $71.90M 10-Q · filed 2014-07-30 | $178.90M 10-Q · filed 2013-07-24 | $298.30M derived: sum of 3 quarters · filed 2015-02-24 | $407.30M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $107.00M 10-Q · filed 2014-04-30 | $226.40M derived: sum of 2 quarters · filed 2015-02-24 | $335.40M derived: sum of 3 quarters · filed 2015-02-24 | $434.30M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $119.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $228.40M derived: sum of 2 quarters · filed 2015-02-24 | $327.30M derived: sum of 3 quarters · filed 2015-02-24 | $483.50M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $109.00M 10-Q · filed 2013-10-23 | $207.90M derived: sum of 2 quarters · filed 2013-10-23 | $364.10M 10-Q · filed 2013-10-23 | $493.10M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | $98.90M 10-Q · filed 2013-07-24 | $255.10M 10-Q · filed 2013-07-24 | $384.10M derived: sum of 3 quarters · filed 2014-02-20 | $467.80M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-03-31 | $156.20M 10-Q · filed 2012-04-25 | $285.20M derived: sum of 2 quarters · filed 2014-02-20 | $368.90M derived: sum of 3 quarters · filed 2014-02-20 | $427.20M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | $129.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $212.70M derived: sum of 2 quarters · filed 2014-02-20 | $271.00M derived: sum of 3 quarters · filed 2014-02-20 | $368.20M 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | $83.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-26 | $142.00M derived: sum of 2 quarters · filed 2011-10-26 | $239.20M 10-Q · filed 2011-10-26 | |||||
| 2011-06-30 | $58.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $155.50M 10-Q · filed 2011-07-27 | ||||||
| 2011-03-31 | $97.20M 10-Q · filed 2011-04-27 | |||||||
| 2010-09-30 | $81.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03 | $218.90M 10-Q · filed 2010-11-03 | ||||||
| 2010-06-30 | $137.30M 10-Q/A · filed 2010-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |